SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

deListed Australia

SEARCH BY NAME

BROWSE

Browse Australian delisted companies0-9A BC DE F GH IJ KL MN OP QR ST UV WX YZ
Browse terminated Australian managed funds0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

CHEMGENEX PHARMACEUTICALS LTD (CXS)

Delisted from ASX 22/07/2011

SHARE PRICES

Former (or subsequent) names

Shareholder links

Our website ranking of CXS: rating 1
(1 out of 5)
COMPANY WEBSITE:

 

REGISTRY:
Link Market Services, Level 15, 324 Queen Street Brisbane QLD 4000
Tel : +61 7 3320 2200 or 1300 554 474
Fax : +61 2 9287 0303
RegistryWebsite RegistryEmail

Company details

Address: C/- LBW Chartered Accountants, 35 Gordon Avenue, Geelong West. Victoria 3218
Tel:  +61 3 5223 9900 Fax: +61 3 5229 0100

Date first listed: 10/07/1986
Company Secretary: Mr Ron Kal
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Pharmaceutical company developing therapeutics in the areas of oncology and hematology
many shareholders in this company have unclaimed money due to them - deListed provides a tracing service for a small administration fee that identifies where people can find unclaimed monies arising from compulsory acquisitions and also from dividend distributions, super contributions, inoperative bank, building society or credit union accounts, bequests and other sources - please click here for access to our Lost shares, Lost money?? service29/02/2012
delisted following completion of the takeover offer made by Cephalon Inc.22/07/2011
we understand Cephalon was successful with off-market takeover offer of $0.70 cash per share and $0.02 cash per listed option22/07/2011
Cephalon CXS Holdings Ltd bought 9,113,676 ChemGenex Pharmaceuticals Ltd shares between July 12 and 15, 2011 via takeover offer, increasing from 304,445,194 shares (97.09%) to 313,558,870 shares (100%)21/07/2011
Cephalon CXS Holdings Ltd bought 12,198,508 ChemGenex Pharmaceuticals Ltd shares between June 15 and July 9, 2011 via takeover offer, increasing from 292,246,686 shares (93.20%) to 304,445,194 shares (97.09%)12/07/2011
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation at the close of trading on Tuesday, 21 June 2011 in accordance with listing rule 17.4, following the issue by Cephalon Inc. of compulsory acquisition notices21/06/2011
shares reinstated to quotation09/04/2009
the securities of ChemGenex Pharmaceuticals Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company08/04/2009
we understand that on or about this date the company made an in specie distribution of 1 share in Autogen Research Pty Ltd for every 5 shares in the company17/12/2007
we understand that on or about this date the company demerged Autogen (subsequently renamed Verva Pharmaceuticals Ltd)15/11/2007
shares reinstated to quotation following receipt of an announcement providing details of the Company's completed capital raising08/05/2006
advises of the intended offer of 35m ordinary shares by placement to selected sophisticated or professional investors04/05/2006
securities suspended from quotation at the request of the company pending the release of an announcement03/05/2006
name changed from AGT Biosciences Limited29/06/2004

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box. If an image appears, enter the word/figures you see in the image.

    Posting your comments. Please wait...

    Directors' on-market share transactions (last 5)

     

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    James CampbellCFO, COO
    Wilco GroenhuysenDirector
    Tony JohnsonDirector
    Ron KalDirector
    Kevin BuchiDirector

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION

    Date of first appointment, title may have changed.